Patients with non-luminal breast cancer (HER2-positive and triple-negative) were more inclined to present focal edema than those with luminal breast cancer with a statistically highly significant p-value (p < 0.001) (Fig. 1b and d). This evidence concerns the gene ERBB2 and breast cancer.